Pharmacogenomics newsletter
Our May pharmcagonomics newsletter shows what has happened over the last 6 months and what’s to come! Contents: Mavacamten and […]
Our May pharmcagonomics newsletter shows what has happened over the last 6 months and what’s to come! Contents: Mavacamten and […]
In April 2023, a guideline was released to provide dosing recommendations for 6-mercaptopurine (6-MP) in adult acute lymphoblastic leukaemia patients […]
In January 2021 the MHRA released a drug safety update on the increased risk of deafness due to a mitochondrial […]
On 14 July 2022 the North Thames Genomic Medicine Service (GMS) held an event showcasing how genomic medicine is transforming […]